Caverject Articles

Alprostadil likely to gain new ED patients

9 October 2001

P&U patient info on Caverject

14 September 1999

First Approval For Senetek's Invicorp

14 July 1998

Viagra Phenomenon Set To Transform Pharma Industry

6 May 1998

Pfizer's Viagra Already Has 95% Share Of ED Market

30 April 1998

PowderJect's Needlefree Alprostadil

22 April 1998

Unprecedented Take-Off For Pfizer's Viagra

21 April 1998

Pfizer's Impotence Pill Wins FDA Clearance

31 March 1998

Fournier's Erecnos Boosted By Clinical Trial Results

8 October 1997

Vivus Shares Tumble On MUSE Concerns

3 March 1997

Dutch Government Reimbursement Blacklist Rises To 35

9 December 1996

China Approves Caverject

15 July 1996

Pfizer's Impotence Pill Shows Promise

13 May 1996

Harvard's Impotence Product

6 May 1996

VIVUS Filed NDA For Impotence Product

8 April 1996

USA Lags Foreign Approvals, PhRMA Demonstrates

16 October 1995

Marriage Of Pharmacia And Upjohn Will Create New $13 Bill Drug Group

4 September 1995

Correction: Upjohn's Minoxidil In Impotence

14 August 1995

Upjohn's Caverject Approved In The USA

17 July 1995

Impotence: Neglected Disorder Set To Undergo Rapid Change

17 July 1995

Two More Launches For Upjohn's Freedox

24 April 1995

CAVERJECT INTRODUCTION IN UK

18 April 1994

FIRST APPROVAL FOR UPJOHN'S CAVERJECT

21 February 1994

Showing 1-23 of 23 articles

Go to beginningPrevious
  • 1
NextGo to end